1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. FUSION PHARMACEUTICALS INC

Fusion Pharmaceuticals Inc

XNAS: FUSN

Watchlist

Portfolio

Share
Board Meeting
The next board meeting for Fusion Pharmaceuticals Inc is on 20 Mar 2025 for the purpose of Fusion Pharmaceuticals Inc Fourth Quarter Earnings Results for 2024 See details


Insider Trading disclosures for Fusion Pharmaceuticals Inc

The latest disclosure was made by Dmitri Bobilev in Fusion Pharmaceuticals Inc where a trade of 91,000 Restricted Stock Units done was reported to US exchanges on Jan. 4, 2024.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Dmitri Bobilev Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jan 2024 91,000 91,000 - - Restricted Stock Units
Dmitri Bobilev Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jan 2024 151,700 151,700 - - Stock Option (Right to Buy)
John Crowley Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jan 2024 106,100 106,100 - - Stock Option (Right to Buy)
John Crowley Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jan 2024 63,700 63,700 - - Restricted Stock Units
Burak Eric Chief Technology Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jan 2024 106,100 106,100 - - Stock Option (Right to Buy)
John Valliant Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jan 2024 320,400 320,400 - - Stock Option (Right to Buy)
John Valliant Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jan 2024 192,200 192,200 - - Restricted Stock Units
Burak Eric Chief Technology Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jan 2024 63,700 63,700 - - Restricted Stock Units
Leamon Christopher Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Aug 2023 106,100 106,100 - - Stock Option (Right to Buy)
Mohit Rawat President & CBO Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Aug 2023 135,500 135,500 - - Stock Option (Right to Buy)
Christopher Leamon Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Aug 2023 63,700 63,700 - - Restricted Stock Units
Rawat Mohit President & CBO Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Aug 2023 12,843 12,843 - - Common Stock
Christopher Leamon Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Aug 2023 11,957 11,957 - - Common Stock
Rawat Mohit President & CBO Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Aug 2023 81,300 81,300 - - Restricted Stock Units
Christopher Leamon Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jan 2023 250,000 250,000 - - Stock Option (Right to Buy)
John Crowley Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jan 2023 250,000 250,000 - - Stock Option (Right to Buy)
John Valliant Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jan 2023 500,000 500,000 - - Stock Option (Right to Buy)
Eric Burak Chief Technology Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jan 2023 250,000 250,000 - - Stock Option (Right to Buy)
Mohit Rawat President and CBO Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jan 2023 300,000 300,000 - - Stock Option (Right to Buy)
Chau Q. Khuong Director Grant, award, or other acquisition of securities at price $ 2.38 per share. 11 Nov 2022 42,093 42,093 - 2.4 100,181 Common Stock
Dmitri Bobilev Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Nov 2022 550,000 550,000 - - Stock Option (Right to Buy)
Steven Gannon Director Purchase of securities on an exchange or from another person at price $ 2.03 per share. 11 Aug 2022 44,400 56,400 - 2.0 90,132 Common Stock
Pablo J. Cagnoni Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2022 17,000 17,000 - - Stock Option (Right to Buy)
Barbara G. Duncan Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2022 17,000 17,000 - - Stock Opion (Right to Buy)
Heather Elizabeth Preston Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2022 17,000 17,000 - - Stock Option (Right to Buy)
Chau Q. Khuong Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2022 17,000 17,000 - - Stock Option (Right to Buy)
Steven Gannon Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2022 17,000 17,000 - - Stock Option (Right to Buy)
Philina Lee Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2022 17,000 17,000 - - Stock Option (Right to Buy)
John Valliant Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 6.07 per share. 25 Apr 2022 2,147 322,658 - 6.1 13,032 Common Stock
John Valliant Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 6.03 per share. 25 Apr 2022 4,511 318,147 - 6.0 27,201 Common Stock
John Valliant Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 6.03 per share. 25 Apr 2022 2,036 324,805 - 6.0 12,277 Common Stock
John Valliant Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 7.10 per share. 11 Apr 2022 18,255 340,124 - 7.1 129,611 Common Stock
John Valliant Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 6.41 per share. 11 Apr 2022 11,994 328,130 - 6.4 76,882 Common Stock
John Valliant Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 7.37 per share. 11 Apr 2022 2,600 358,379 - 7.4 19,162 Common Stock
John Valliant Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 7.58 per share. 06 Apr 2022 100 363,060 - 7.6 758 Common Stock
John Valliant Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 7.52 per share. 06 Apr 2022 826 360,979 - 7.5 6,212 Common Stock
John Valliant Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 7.56 per share. 06 Apr 2022 1,255 361,805 - 7.6 9,488 Common Stock
John Valliant Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 7.67 per share. 01 Apr 2022 2,100 363,160 - 7.7 16,107 Common Stock
John Valliant Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 7.81 per share. 01 Apr 2022 700 365,260 - 7.8 5,467 Common Stock
John Valliant Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 7.75 per share. 01 Apr 2022 1,000 365,960 - 7.8 7,750 Common Stock
John Valliant Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 7.52 per share. 30 Mar 2022 300 366,960 - 7.5 2,256 Common Stock
John Valliant Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 7.55 per share. 25 Mar 2022 9,600 367,460 - 7.6 72,480 Common Stock
John Valliant Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 7.52 per share. 25 Mar 2022 200 367,260 - 7.5 1,504 Common Stock
John Valliant Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 7.42 per share. 25 Mar 2022 500 377,060 - 7.4 3,710 Common Stock
John Valliant Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 7.53 per share. 22 Mar 2022 4,000 378,360 - 7.5 30,120 Common Stock
John Valliant Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 7.46 per share. 22 Mar 2022 700 377,560 - 7.5 5,222 Common Stock
John Valliant Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 7.50 per share. 22 Mar 2022 100 378,260 - 7.5 750 Common Stock
John Valliant Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 7.61 per share. 17 Mar 2022 1,204 383,860 - 7.6 9,162 Common Stock
John Valliant Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 7.51 per share. 17 Mar 2022 900 385,064 - 7.5 6,759 Common Stock
John Valliant Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 7.47 per share. 17 Mar 2022 1,500 382,360 - 7.5 11,205 Common Stock
John Valliant Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 6.99 per share. 14 Mar 2022 100 385,964 - 7.0 699 Common Stock
John Valliant Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 7.12 per share. 14 Mar 2022 100 386,064 - 7.1 712 Common Stock
John Valliant Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 6.96 per share. 14 Mar 2022 1,300 386,164 - 7.0 9,048 Common Stock
John Valliant Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 6.94 per share. 09 Mar 2022 822 389,464 - 6.9 5,705 Common Stock
John Valliant Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 7.13 per share. 09 Mar 2022 100 387,464 - 7.1 713 Common Stock
John Valliant Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 7.06 per share. 09 Mar 2022 1,900 387,564 - 7.1 13,414 Common Stock
John Valliant Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 6.99 per share. 04 Mar 2022 3,100 393,290 - 7.0 21,669 Common Stock
John Valliant Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 6.92 per share. 04 Mar 2022 3,004 390,286 - 6.9 20,788 Common Stock
John Valliant Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 7.32 per share. 04 Mar 2022 8,400 396,390 - 7.3 61,488 Common Stock
John Valliant Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 7.44 per share. 01 Mar 2022 26,546 404,990 - 7.4 197,502 Common Stock
John Valliant Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 7.28 per share. 01 Mar 2022 200 404,790 - 7.3 1,456 Common Stock
John Valliant Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 7.37 per share. 01 Mar 2022 847 431,536 - 7.4 6,242 Common Stock
John Valliant Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 7.57 per share. 24 Feb 2022 8,152 435,483 - 7.6 61,711 Common Stock
John Valliant Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 7.40 per share. 24 Feb 2022 3,100 432,383 - 7.4 22,940 Common Stock
John Valliant Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 7.41 per share. 24 Feb 2022 2,500 443,635 - 7.4 18,525 Common Stock
John Valliant Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 7.85 per share. 18 Feb 2022 4,100 475,434 - 7.9 32,185 Common Stock
John Valliant Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 7.77 per share. 18 Feb 2022 29,299 446,135 - 7.8 227,653 Common Stock
John Valliant Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 7.88 per share. 18 Feb 2022 4,898 479,534 - 7.9 38,596 Common Stock
John Valliant Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 7.99 per share. 15 Feb 2022 33,202 486,132 - 8.0 265,284 Common Stock
John Valliant Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 7.98 per share. 15 Feb 2022 1,700 484,432 - 8.0 13,566 Common Stock
John Valliant Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 8.33 per share. 15 Feb 2022 12,600 519,334 - 8.3 104,958 Common Stock
James J. O'Leary Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2022 159,000 159,000 - - Stock Option (Right to Buy)
James J. O'Leary Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2022 1,722 2,022 - - Common Stock
John Crowley Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2022 167,000 167,000 - - Stock Option (Right to Buy)
John Crowley Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2022 3,910 10,410 - - Common Stock
John Valliant Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2022 406,600 406,600 - - Stock Option (Right to Buy)
Eric Burak Chief? Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2022 168,200 168,200 - - Stock Option (Right to Buy)
Mohit Rawat President and CBO Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2022 77,900 77,900 - - Stock Option (Right to Buy)
Christopher Leamon Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Nov 2021 218,000 218,000 - - Stock Option (Right to Buy)
Mohit Rawat President and CBO Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Sep 2021 257,000 257,000 - - Stock Option (Right to Buy)
Steven Gannon Director Purchase of securities on an exchange or from another person at price $ 7.99 per share. 23 Aug 2021 2,829 12,000 - 8.0 22,590 Common Stock
Steven Gannon Director Purchase of securities on an exchange or from another person at price $ 8.05 per share. 18 Aug 2021 3,000 9,171 - 8.1 24,150 Common Stock
Steven Gannon Director Purchase of securities on an exchange or from another person at price $ 8.05 per share. 18 Aug 2021 171 6,171 - 8.1 1,377 Common Stock
Steven Gannon Director Purchase of securities on an exchange or from another person at price $ 8.10 per share. 16 Aug 2021 6,000 6,000 - 8.1 48,600 Common Stock
Donald A. Bergstrom Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2021 17,000 17,000 - - Stock Option (Right to Buy)
Pablo J. Cagnoni Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2021 17,000 17,000 - - Stock Option (Right to Buy)
Barbara G. Duncan Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2021 17,000 17,000 - - Stock Opion (Right to Buy)
Heather Elizabeth Preston Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2021 17,000 17,000 - - Stock Option (Right to Buy)
Chau Q. Khuong Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2021 17,000 17,000 - - Stock Option (Right to Buy)
Steven Gannon Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2021 17,000 17,000 - - Stock Option (Right to Buy)
Donald A. Bergstrom Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2021 17,000 17,000 - - Stock Option (Right to Buy)
Philina Lee Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2021 17,000 17,000 - - Stock Option (Right to Buy)
Donald A. Bergstrom Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Apr 2021 34,000 34,000 - - Stock Option (Right to Buy)
Philina Lee Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Feb 2021 30,000 30,000 - - Stock Option (Right to Buy)
James J. O'Leary Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Feb 2021 114,000 114,000 - - Stock Option (Right to Buy)
John Crowley Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Feb 2021 138,000 138,000 - - Stock Option (Right to Buy)
John Valliant Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Feb 2021 336,000 336,000 - - Stock Option (Right to Buy)
Eric Burak Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Feb 2021 136,600 136,600 - - Stock Option (Right to Buy)
Eric Burak Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Feb 2021 41,000 41,000 - - Stock Option (Right to Buy)
Eric Burak Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Feb 2021 139,000 139,000 - - Stock Option (Right to Buy)
Barbara G. Duncan Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Oct 2020 30,000 30,000 - - Stock Option (Right to Buy)
James J. O'Leary Chief Medical Officer Purchase of securities on an exchange or from another person at price $ 17.00 per share. 30 Jun 2020 300 300 - 17 5,100 Common Stock
John Crowley Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 17.00 per share. 30 Jun 2020 6,500 6,500 - 17 110,500 Common Stock
Heather Preston Director Purchase of securities on an exchange or from another person at price $ 17.00 per share. 30 Jun 2020 8,823 8,823 - 17 149,991 Common Stock
Chau Q. Khuong Director 30 Jun 2020 11,878,051 0 - - Class B Preferred Shares
Chau Q. Khuong Director Purchase of securities on an exchange or from another person at price $ 17.00 per share. 30 Jun 2020 192,100 192,100 - 17 3,265,700 Common Shares
Chau Q. Khuong Director Purchase of securities on an exchange or from another person at price $ 17.00 per share. 30 Jun 2020 705,900 2,930,670 - 17 12,000,300 Common Shares
Chau Q. Khuong Director 30 Jun 2020 2,224,770 2,224,770 - - Common Shares
Johan Christenson Director Purchase of securities on an exchange or from another person at price $ 17.00 per share. 30 Jun 2020 240,000 3,807,247 - 17 4,080,000 Common Shares
Johan Christenson Director 30 Jun 2020 13,333,333 0 - - Class A Preferred Exchangeable Shares
Johan Christenson Director 30 Jun 2020 2,497,345 2,497,345 - - Common Shares
Johan Christenson Director 30 Jun 2020 5,712,216 0 - - Class B Preferred Exchangeable Shares
Johan Christenson Director 30 Jun 2020 1,069,902 3,567,247 - - Common Shares
Pablo J. Cagnoni Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jun 2020 30,000 30,000 - - Stock Option (Right to Buy)
James J. O'Leary Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jun 2020 351,921 351,921 - - Stock Option (Right to Buy)
James J. O'Leary Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jun 2020 26,971 26,971 - - Stock Option (Right to Buy)
James J. O'Leary Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jun 2020 60,852 60,852 - - Stock Option (Right to Buy)
John Crowley Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jun 2020 26,972 26,972 - - Stock Option (Right to Buy)
John Crowley Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jun 2020 38,561 38,561 - - Stock Option (Right to Buy)
John Crowley Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jun 2020 60,852 60,852 - - Stock Option (Right to Buy)
Heather Preston Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jun 2020 30,000 30,000 - - Stock Option (Right to Buy)
Chau Q. Khuong Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jun 2020 359,377 359,377 - - Warrants to Purchase Class B Preferred Shares
Chau Q. Khuong Director Purchase of securities on an exchange or from another person at price $ 0.00 per share. 25 Jun 2020 5,939,025 11,878,051 - - Class B Preferred Shares
Chau Q. Khuong Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jun 2020 30,000 30,000 - - Stock Option (Right to Buy)
Steven Gannon Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jun 2020 30,000 30,000 - - Stock Option (Right to Buy)
Steven Gannon Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jun 2020 141,011 141,011 - - Stock Option (Right to Buy)
Damian Lamb Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jun 2020 30,000 30,000 - - Stock Option (Right to Buy)
Johan Christenson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jun 2020 576,233 576,233 - - Warrants to purchase Class B Preferred Exchangeable Shares
Johan Christenson Director Purchase of securities on an exchange or from another person at price $ 0.00 per share. 25 Jun 2020 2,856,108 5,712,216 - - Class B Preferred Exchangeable Shares
Johan Christenson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jun 2020 30,000 30,000 - - Stock Option (Right to Buy)
John Valliant Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jun 2020 173,528 173,528 - - Stock Option (Right to Buy)
John Valliant Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jun 2020 372,948 372,948 - - Stock Option (Right to Buy)
John Valliant Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jun 2020 206,541 206,541 - - Stock Option (Right to Buy)
Eric Burak Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jun 2020 38,561 38,561 - - Stock Option (Right to Buy)
Eric Burak Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jun 2020 44,754 44,754 - - Stock Option (Right to Buy)
Eric Burak Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jun 2020 69,980 69,980 - - Stock Option (Right to Buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters